ADMA Biologics, Inc. (ADMA)
8.42
-0.08
(-0.94%)
USD |
NASDAQ |
May 15, 10:03
ADMA Biologics Total Liabilities (Quarterly) : 274.86M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Inovio Pharmaceuticals, Inc. | 43.71M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| AnaptysBio, Inc. | 316.94M |
| Kodiak Sciences, Inc. | 193.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 665.18M |
| Shareholders Equity (Quarterly) | 390.32M |
| Debt to Equity Ratio | 0.5237 |
| Current Ratio | 6.951 |
| Net Debt Paydown Yield | -1.17% |